Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

Outcome Priorities for Older Persons With Sarcopenia.

Hiligsmann M, Beaudart C, Bruyère O, Biver E, Bauer J, Cruz-Jentoft AJ, Gesmundo A, Goisser S, Landi F, Locquet M, Maggi S, Rizzoli R, Rolland Y, Vaquero N, Cooper C, Reginster JY; European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

J Am Med Dir Assoc. 2019 Oct 28. pii: S1525-8610(19)30643-7. doi: 10.1016/j.jamda.2019.08.026. [Epub ahead of print]

2.

Patient's Engagement in the Identification of Critical Outcomes in Sarcopenia.

Beaudart C, Bruyère O, Cruz-Jentoft AJ, Vaquero-Pinto MN, Locquet M, Bauer J, Cooper C, Rolland Y, Dupuy C, Landi F, Reginster JY, Maggi S, Rizzoli R, Hiligsmann M; European Society for Clinical and Economic Aspect of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

J Am Med Dir Assoc. 2019 Oct 24. pii: S1525-8610(19)30654-1. doi: 10.1016/j.jamda.2019.09.004. [Epub ahead of print] No abstract available.

PMID:
31668737
3.

Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management.

Dent E, Morley JE, Cruz-Jentoft AJ, Woodhouse L, Rodríguez-Mañas L, Fried LP, Woo J, Aprahamian I, Sanford A, Lundy J, Landi F, Beilby J, Martin FC, Bauer JM, Ferrucci L, Merchant RA, Dong B, Arai H, Hoogendijk EO, Won CW, Abbatecola A, Cederholm T, Strandberg T, Gutiérrez Robledo LM, Flicker L, Bhasin S, Aubertin-Leheudre M, Bischoff-Ferrari HA, Guralnik JM, Muscedere J, Pahor M, Ruiz J, Negm AM, Reginster JY, Waters DL, Vellas B.

J Nutr Health Aging. 2019;23(9):771-787. doi: 10.1007/s12603-019-1273-z.

4.

Fall-risk increasing drugs and recurrent injurious falls association in older patients after hip fracture: a cohort study protocol.

Correa-Pérez A, Delgado-Silveira E, Martín-Aragón S, Cruz-Jentoft AJ.

Ther Adv Drug Saf. 2019 Sep 27;10:2042098619868640. doi: 10.1177/2042098619868640. eCollection 2019.

5.

Older women are frailer, but less often die then men: a prospective study of older hospitalized people.

Veronese N, Siri G, Cella A, Daragjati J, Cruz-Jentoft AJ, Polidori MC, Mattace-Raso F, Paccalin M, Topinkova E, Greco A, Mangoni AA, Maggi S, Ferrucci L, Pilotto A; MPI AGE Investigators.

Maturitas. 2019 Oct;128:81-86. doi: 10.1016/j.maturitas.2019.07.025. Epub 2019 Aug 3.

PMID:
31561828
6.

Sarcopenia: A Time for Action. An SCWD Position Paper.

Bauer J, Morley JE, Schols AMWJ, Ferrucci L, Cruz-Jentoft AJ, Dent E, Baracos VE, Crawford JA, Doehner W, Heymsfield SB, Jatoi A, Kalantar-Zadeh K, Lainscak M, Landi F, Laviano A, Mancuso M, Muscaritoli M, Prado CM, Strasser F, von Haehling S, Coats AJS, Anker SD.

J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):956-961. doi: 10.1002/jcsm.12483. Epub 2019 Sep 15.

7.

Enteral tube feeding and mortality in hospitalized older patients: A multicenter longitudinal study.

Veronese N, Cella A, Cruz-Jentoft AJ, Polidori MC, Mattace-Raso F, Paccalin M, Topinkova E, Greco A, Mangoni AA, Daragjati J, Siri G, Pilotto A; MPI_AGE Investigators.

Clin Nutr. 2019 Jul 22. pii: S0261-5614(19)30293-6. doi: 10.1016/j.clnu.2019.07.011. [Epub ahead of print]

PMID:
31378515
8.

Correction to: Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review.

Bauer JM, Cruz-Jentoft AJ, Fielding RA, Kanis JA, Reginster JY, Bruyère O, Cesari M, Chapurlat R, Al-Daghri N, Dennison E, Kaufman JM, Landi F, Laslop A, Locquet M, Maggi S, McCloskey E, Perna S, Rizzoli R, Rolland Y, Rondanelli M, Szulc P, Vellas B, Vlaskovska M, Cooper C.

Calcif Tissue Int. 2019 Aug;105(2):125-126. doi: 10.1007/s00223-019-00587-0.

PMID:
31338562
9.

Detecting sarcopenia in the older diabetic adults.

Bahat G, Erdogan T, Cruz-Jentoft AJ.

Aging Clin Exp Res. 2019 Aug;31(8):1181-1182. doi: 10.1007/s40520-019-01272-w. Epub 2019 Jul 18. No abstract available.

PMID:
31321742
10.

Paternalism vs. Autonomy: Are They Alternative Types of Formal Care?

Fernández-Ballesteros R, Sánchez-Izquierdo M, Olmos R, Huici C, Ribera Casado JM, Cruz Jentoft A.

Front Psychol. 2019 Jun 28;10:1460. doi: 10.3389/fpsyg.2019.01460. eCollection 2019. No abstract available.

11.

[Prevalence of sarcopenia and characteristics of sarcopenic subjects in patients over 80 years with hip fracture].

Sánchez-Castellano C, Martín-Aragón S, Vaquero-Pinto N, Bermejo-Bescós P, Merello de Miguel A, Cruz-Jentoft AJ.

Version 2. Nutr Hosp. 2019 Jul 10 [revised 2019 Jan 1]. doi: 10.20960/nh.02607. [Epub ahead of print] Spanish.

12.

Development and validation of a paternalism and autonomist care assessment.

Fernández-Ballesteros R, Sánchez-Izquierdo M, Olmos R, Huici C, Caprara MG, Santacreu M, Ribera Casado JM, Cruz-Jentoft A.

J Adv Nurs. 2019 Jul 9. doi: 10.1111/jan.14154. [Epub ahead of print]

PMID:
31287167
13.

Management of Malnutrition in Older Patients-Current Approaches, Evidence and Open Questions.

Volkert D, Beck AM, Cederholm T, Cereda E, Cruz-Jentoft A, Goisser S, de Groot L, Großhauser F, Kiesswetter E, Norman K, Pourhassan M, Reinders I, Roberts HC, Rolland Y, Schneider SM, Sieber CC, Thiem U, Visser M, Wijnhoven HAH, Wirth R.

J Clin Med. 2019 Jul 4;8(7). pii: E974. doi: 10.3390/jcm8070974. Review.

14.
15.

Sarcopenia.

Cruz-Jentoft AJ, Sayer AA.

Lancet. 2019 Jun 29;393(10191):2636-2646. doi: 10.1016/S0140-6736(19)31138-9. Epub 2019 Jun 3. Review. Erratum in: Lancet. 2019 Jun 29;393(10191):2590.

PMID:
31171417
16.

The value of sarcopenia in the prevention of disability.

Montero-Errasquín B, Cruz-Jentoft AJ.

Med Clin (Barc). 2019 Sep 27;153(6):243-244. doi: 10.1016/j.medcli.2019.03.006. Epub 2019 May 26. English, Spanish. No abstract available.

PMID:
31138445
17.

Nonpharmacologic Management of Orthostatic Hypotension in Older People: A Systematic Review. The SENATOR ONTOP Series.

Subbarayan S, Myint PK, Martin KR, Abraha I, Devkota S, O'Mahony D, Cruz-Jentoft AJ, Cherubini A, Soiza RL.

J Am Med Dir Assoc. 2019 Sep;20(9):1065-1073.e3. doi: 10.1016/j.jamda.2019.03.032. Epub 2019 May 17. Review.

PMID:
31109911
18.

Is There Enough Evidence for Osteosarcopenic Obesity as a Distinct Entity? A Critical Literature Review.

Bauer JM, Cruz-Jentoft AJ, Fielding RA, Kanis JA, Reginster JY, Bruyère O, Cesari M, Chapurlat R, Al-Daghri N, Dennison E, Kaufman JM, Landi F, Laslop A, Locquet M, Maggi S, McCloskey E, Perna S, Rizzoli R, Rolland Y, Rondanelli M, Szulc P, Vellas B, Vlaskovska M, Cooper C.

Calcif Tissue Int. 2019 Aug;105(2):109-124. doi: 10.1007/s00223-019-00561-w. Epub 2019 May 16. Review. Erratum in: Calcif Tissue Int. 2019 Jul 23;:.

PMID:
31098729
19.

Sarcopenia: revised European consensus on definition and diagnosis.

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2.

Age Ageing. 2019 Jul 1;48(4):601. doi: 10.1093/ageing/afz046. No abstract available.

20.

Clinical characteristics and prognosis for delirium in Spanish internal medicine departments: An analysis from a large clinical-administrative database.

Marco J, Méndez M, Cruz-Jentoft AJ, García Klepzig JL, Calvo E, Canora J, Zapatero A, Barba R.

Rev Clin Esp. 2019 Nov;219(8):415-423. doi: 10.1016/j.rce.2019.02.005. Epub 2019 Apr 20. English, Spanish.

PMID:
31014566
21.

Association of different bioimpedanciometry estimations of muscle mass with functional measures.

Bahat G, Kilic C, Ilhan B, Karan MA, Cruz-Jentoft A.

Geriatr Gerontol Int. 2019 Jul;19(7):593-597. doi: 10.1111/ggi.13668. Epub 2019 Apr 21.

PMID:
31006968
22.

Assessment of Muscle Function and Physical Performance in Daily Clinical Practice : A position paper endorsed by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO).

Beaudart C, Rolland Y, Cruz-Jentoft AJ, Bauer JM, Sieber C, Cooper C, Al-Daghri N, Araujo de Carvalho I, Bautmans I, Bernabei R, Bruyère O, Cesari M, Cherubini A, Dawson-Hughes B, Kanis JA, Kaufman JM, Landi F, Maggi S, McCloskey E, Petermans J, Rodriguez Mañas L, Reginster JY, Roller-Wirnsberger R, Schaap LA, Uebelhart D, Rizzoli R, Fielding RA.

Calcif Tissue Int. 2019 Jul;105(1):1-14. doi: 10.1007/s00223-019-00545-w. Epub 2019 Apr 10. Review.

PMID:
30972475
23.

Nutritional interventions to prevent and treat frailty.

Cruz-Jentoft AJ, Woo J.

Curr Opin Clin Nutr Metab Care. 2019 May;22(3):191-195. doi: 10.1097/MCO.0000000000000556.

PMID:
30829853
24.

[Ten recommendations to improve undergraduate training in Geriatric Medicine].

Mateos-Nozal J, Farré-Mercadé MV, Cruz-Jentoft AJ, Ribera Casado JM; Grupo de Enseñanza de la Geriatría en el pregrado de la Sociedad Española de Geriatría y Gerontología; Miembros del Grupo de Enseñanza de la Geriatría en el pregrado.

Rev Esp Geriatr Gerontol. 2019 Jul - Aug;54(4):203-206. doi: 10.1016/j.regg.2018.12.005. Epub 2019 Feb 15. Spanish.

PMID:
30777383
25.

The authors reply: Letter on: "Pitfalls in the measurement of muscle mass: a need for a reference standard" by Clark et al.

Buckinx F, Landi F, Cesari M, Fieding RA, Visser M, Engelke K, Maggi S, Dennison E, Al-Daghri NM, Allepaerts S, Bauer J, Bautmans I, Brandi ML, Bruyère O, Cederholm T, Cerreta F, Cherubini A, Cooper C, Cruz-Jentoft A, McCloskey E, Dawson-Hughes B, Kaufman JM, Laslop A, Petermans J, Reginster JY, Rizzoli R, Robinson S, Rolland Y, Rueda R, Vellas B, Kanis JA.

J Cachexia Sarcopenia Muscle. 2018 Dec;9(7):1272-1274. doi: 10.1002/jcsm.12387.

26.

Planning to reduce 30-day adverse events after discharge of frail elderly patients with acute heart failure: design and rationale for the DEED FRAIL-AHF trial.

Martín-Sánchez FJ, Llopis García G, Llorens P, Jacob J, Herrero P, Gil V, Pastor AJ, López-Picado A, Fuentes Ferrer M, Rosselló X, Gil P, Díez Villanueva P, Calvo E, Méndez Bailón M, Cuesta-Triana F, González Armengol JJ, González Del Castillo J, Runtkle I, Vidán MT, Comín-Colet J, Cruz Jentoft A, Bueno H, Miró Ò, Fernández Pérez C.

Emergencias. 2019 Feb;31(1):27-35. English, Spanish.

27.

[Inappropriate drug use in palliative care: SPANISH version of the STOPP-Frail criteria (STOPP-Pal)].

Delgado-Silveira E, Mateos-Nozal J, Muñoz García M, Rexach Cano L, Vélez-Díaz-Pallarés M, Albeniz López J, Cruz-Jentoft AJ.

Rev Esp Geriatr Gerontol. 2019 May - Jun;54(3):151-155. doi: 10.1016/j.regg.2018.11.008. Epub 2018 Dec 31. Spanish.

PMID:
30606497
28.

The Underappreciated Role of Low Muscle Mass in the Management of Malnutrition.

Deutz NEP, Ashurst I, Ballesteros MD, Bear DE, Cruz-Jentoft AJ, Genton L, Landi F, Laviano A, Norman K, Prado CM.

J Am Med Dir Assoc. 2019 Jan;20(1):22-27. doi: 10.1016/j.jamda.2018.11.021.

29.

Muscle loss: The new malnutrition challenge in clinical practice.

Landi F, Camprubi-Robles M, Bear DE, Cederholm T, Malafarina V, Welch AA, Cruz-Jentoft AJ.

Clin Nutr. 2019 Oct;38(5):2113-2120. doi: 10.1016/j.clnu.2018.11.021. Epub 2018 Nov 30.

PMID:
30553578
30.

International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management.

Dent E, Morley JE, Cruz-Jentoft AJ, Arai H, Kritchevsky SB, Guralnik J, Bauer JM, Pahor M, Clark BC, Cesari M, Ruiz J, Sieber CC, Aubertin-Leheudre M, Waters DL, Visvanathan R, Landi F, Villareal DT, Fielding R, Won CW, Theou O, Martin FC, Dong B, Woo J, Flicker L, Ferrucci L, Merchant RA, Cao L, Cederholm T, Ribeiro SML, Rodríguez-Mañas L, Anker SD, Lundy J, Gutiérrez Robledo LM, Bautmans I, Aprahamian I, Schols JMGA, Izquierdo M, Vellas B.

J Nutr Health Aging. 2018;22(10):1148-1161. doi: 10.1007/s12603-018-1139-9.

PMID:
30498820
31.

Using the Multidimensional Prognostic Index to Predict Clinical Outcomes of Hospitalized Older Persons: A Prospective, Multicenter, International Study.

Pilotto A, Veronese N, Daragjati J, Cruz-Jentoft AJ, Polidori MC, Mattace-Raso F, Paccalin M, Topinkova E, Siri G, Greco A, Mangoni AA, Maggi S, Ferrucci L; MPI_AGE Investigators .

J Gerontol A Biol Sci Med Sci. 2019 Sep 15;74(10):1643-1649. doi: 10.1093/gerona/gly239.

PMID:
30329033
32.

Sarcopenia: revised European consensus on definition and diagnosis.

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2.

Age Ageing. 2019 Jan 1;48(1):16-31. doi: 10.1093/ageing/afy169. Erratum in: Age Ageing. 2019 Jul 1;48(4):601.

33.

Prevalence of sarcopenia and its components in community-dwelling outpatient older adults and their relation with functionality.

Bahat G, Tufan A, Kilic C, Karan MA, Cruz-Jentoft AJ.

Aging Male. 2018 Oct 5:1-7. doi: 10.1080/13685538.2018.1511976. [Epub ahead of print]

PMID:
30290756
34.

Non-pharmacological interventions for the improvement of post-stroke activities of daily living and disability amongst older stroke survivors: A systematic review.

Stewart C, Subbarayan S, Paton P, Gemmell E, Abraha I, Myint PK, O'Mahony D, Cruz-Jentoft AJ, Cherubini A, Soiza RL.

PLoS One. 2018 Oct 4;13(10):e0204774. doi: 10.1371/journal.pone.0204774. eCollection 2018.

35.

Fall-risk increasing drugs and prevalence of polypharmacy in older patients discharged from an Orthogeriatric Unit after a hip fracture.

Correa-Pérez A, Delgado-Silveira E, Martín-Aragón S, Rojo-Sanchís AM, Cruz-Jentoft AJ.

Aging Clin Exp Res. 2019 Jul;31(7):969-975. doi: 10.1007/s40520-018-1046-2. Epub 2018 Oct 1.

PMID:
30276631
36.

Cut-off points for height, weight and body mass index adjusted bioimpedance analysis measurements of muscle mass with use of different threshold definitions.

Bahat G, Tufan A, Kilic C, Aydın T, Akpinar TS, Kose M, Erten N, Karan MA, Cruz-Jentoft AJ.

Aging Male. 2018 Sep 29:1-6. doi: 10.1080/13685538.2018.1499081. [Epub ahead of print]

PMID:
30269625
37.

Cut-off points for weight and body mass index adjusted bioimpedance analysis measurements of muscle mass.

Bahat G, Tufan A, Kilic C, Öztürk S, Akpinar TS, Kose M, Erten N, Karan MA, Cruz-Jentoft AJ.

Aging Clin Exp Res. 2019 Jul;31(7):935-942. doi: 10.1007/s40520-018-1042-6. Epub 2018 Sep 28.

PMID:
30267332
38.

The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: Case finding, screening and characteristics of eligible participants.

Marzetti E, Cesari M, Calvani R, Msihid J, Tosato M, Rodriguez-Mañas L, Lattanzio F, Cherubini A, Bejuit R, Di Bari M, Maggio M, Vellas B, Dantoine T, Cruz-Jentoft AJ, Sieber CC, Freiberger E, Skalska A, Grodzicki T, Sinclair AJ, Topinkova E, Rýznarová I, Strandberg T, Schols AMWJ, Schols JMGA, Roller-Wirnsberger R, Jónsson PV, Ramel A, Del Signore S, Pahor M, Roubenoff R, Bernabei R, Landi F; SPRINTT Consortium.

Exp Gerontol. 2018 Nov;113:48-57. doi: 10.1016/j.exger.2018.09.017. Epub 2018 Sep 24.

39.

The Authors reply: "Dual energy X-ray absorptiometry: gold standard for muscle mass?" by Scafoglieri et al.

Buckinx F, Landi F, Cesari M, Fieding RA, Visser M, Engelke K, Maggi S, Dennison E, Al-Daghri NM, Allepaerts S, Bauer J, Bautmans I, Brandi ML, Bruyère O, Cederholm T, Cerreta F, Cherubini A, Cooper C, Cruz-Jentoft A, McCloskey E, Dawson-Hughes B, Kaufman JM, Laslop A, Petermans J, Reginster JY, Rizzoli R, Robinson S, Rolland Y, Rueda R, Vellas B, Kanis JA.

J Cachexia Sarcopenia Muscle. 2018 Aug;9(4):788-790. doi: 10.1002/jcsm.12329. Epub 2018 Aug 14. No abstract available.

40.

[The increasing relevance of physical performance in global geriatric assessment].

Sánchez E, Formiga F, Cruz-Jentoft A.

Rev Esp Geriatr Gerontol. 2018 Sep - Oct;53(5):243-244. doi: 10.1016/j.regg.2018.06.002. Epub 2018 Jul 30. Spanish. No abstract available.

PMID:
30072182
41.

ESPEN guideline on clinical nutrition and hydration in geriatrics.

Volkert D, Beck AM, Cederholm T, Cruz-Jentoft A, Goisser S, Hooper L, Kiesswetter E, Maggio M, Raynaud-Simon A, Sieber CC, Sobotka L, van Asselt D, Wirth R, Bischoff SC.

Clin Nutr. 2019 Feb;38(1):10-47. doi: 10.1016/j.clnu.2018.05.024. Epub 2018 Jun 18.

PMID:
30005900
42.

Role of Oral Nutritional Supplements Enriched with β-Hydroxy-β-Methylbutyrate in Maintaining Muscle Function and Improving Clinical Outcomes in Various Clinical Settings.

Sanz-Paris A, Camprubi-Robles M, Lopez-Pedrosa JM, Pereira SL, Rueda R, Ballesteros-Pomar MD, Garcia Almeida JM, Cruz-Jentoft AJ.

J Nutr Health Aging. 2018;22(6):664-675. doi: 10.1007/s12603-018-0995-7. Review.

43.

Implications of ICD-10 for Sarcopenia Clinical Practice and Clinical Trials: Report by the International Conference on Frailty and Sarcopenia Research Task Force.

Vellas B, Fielding RA, Bens C, Bernabei R, Cawthon PM, Cederholm T, Cruz-Jentoft AJ, Del Signore S, Donahue S, Morley J, Pahor M, Reginster JY, Rodriguez Mañas L, Rolland Y, Roubenoff R, Sinclair A, Cesari M.

J Frailty Aging. 2018;7(1):2-9. doi: 10.14283/jfa.2017.30.

PMID:
29412436
44.

Pitfalls in the measurement of muscle mass: a need for a reference standard.

Buckinx F, Landi F, Cesari M, Fielding RA, Visser M, Engelke K, Maggi S, Dennison E, Al-Daghri NM, Allepaerts S, Bauer J, Bautmans I, Brandi ML, Bruyère O, Cederholm T, Cerreta F, Cherubini A, Cooper C, Cruz-Jentoft A, McCloskey E, Dawson-Hughes B, Kaufman JM, Laslop A, Petermans J, Reginster JY, Rizzoli R, Robinson S, Rolland Y, Rueda R, Vellas B, Kanis JA.

J Cachexia Sarcopenia Muscle. 2018 Apr;9(2):269-278. doi: 10.1002/jcsm.12268. Epub 2018 Jan 19.

45.

Incident adverse drug reactions in geriatric inpatients: a multicentred observational study.

Lavan A, Eustace J, Dahly D, Flanagan E, Gallagher P, Cullinane S, Petrovic M, Perehudoff K, Gudmondsson A, Samuelsson Ó, Sverrisdóttir Á, Cherubin A, Dimitri F, Rimland J, Cruz-Jentoft A, Vélez-Díaz-Pallarés M, Lozano Montoya I, Soiza RL, Subbarayan S, O'Mahony D.

Ther Adv Drug Saf. 2018 Jan;9(1):13-23. doi: 10.1177/2042098617736191. Epub 2017 Oct 24.

46.

How clinical practitioners assess frailty in their daily practice: an international survey.

Bruyère O, Buckinx F, Beaudart C, Reginster JY, Bauer J, Cederholm T, Cherubini A, Cooper C, Cruz-Jentoft AJ, Landi F, Maggi S, Rizzoli R, Sayer AA, Sieber C, Vellas B, Cesari M; ESCEO and the EUGMS frailty working group.

Aging Clin Exp Res. 2017 Oct;29(5):905-912. doi: 10.1007/s40520-017-0806-8. Epub 2017 Aug 2.

47.

Influence of nutritional status in the diagnosis of sarcopenia in nursing home residents.

Lardiés-Sánchez B, Sanz-París A, Pérez-Nogueras J, Serrano-Oliver A, Torres-Anoro ME, Cruz-Jentoft AJ.

Nutrition. 2017 Sep;41:51-57. doi: 10.1016/j.nut.2017.03.002. Epub 2017 Apr 7.

PMID:
28760428
48.

Cut-off Points for Muscle Mass - Not Grip Strength or Gait Speed - Determine Variations in Sarcopenia Prevalence.

Masanés F, Rojano I Luque X, Salvà A, Serra-Rexach JA, Artaza I, Formiga F, Cuesta F, López Soto A, Ruiz D, Cruz-Jentoft AJ.

J Nutr Health Aging. 2017;21(7):825-829. doi: 10.1007/s12603-016-0844-5.

PMID:
28717813
49.

Sarcopenia: what should a pharmacist know?

Cruz-Jentoft AJ.

Farm Hosp. 2017 Jul 1;41(4):543-549. doi: 10.7399/fh.2017.41.4.10802. Review.

50.

Beta-Hydroxy-Beta-Methyl Butyrate (HMB): From Experimental Data to Clinical Evidence in Sarcopenia.

Cruz-Jentoft AJ.

Curr Protein Pept Sci. 2018;19(7):668-672. doi: 10.2174/1389203718666170529105026. Review.

PMID:
28554316

Supplemental Content

Loading ...
Support Center